The estrogen proliferative signal, which plays important roles in reproductive tissue function and tumorigenesis, is tightly controlled by the counterbalancing influences of coactivators and corepressors. Our objectives are to determine the importance of 'phosphorylation codes'in maintaining the balance in protein levels between steroid receptor coactivator-3 (SRC-3) and the corepressors, Represser of Estrogen Action (REA) and prohibitin (PHB). Together, they provide a balance which is necessary for normal cellular responses to estrogen. We will determine the physiological consequences of perturbing this coregulator homeostasis on steroid-induced mammary ontogenesis and oncogenesis. For SRC-3, we have identified two distinct phosphorylation codes which exert opposing effects on its protein stability. While atypical protein kinase C zeta promotes SRC-3 stabilization, glucose synthase kinase 3 (GSK3) promotes SRC-3 degradation. Like SRC-3, we have evidence that REA and PHB also operate as phosphoproteins. Based on the foregoing, we hypothesize that permutations of phosphorylation sites on SRC-3, REA and PHB constitute a 'phosphorylation code', which not only codes for coactivator/corepressor activation states but defines the stability of these coregulators. We predict that the phosphorylation code is a pivotal post- translational mechanism that maintains a critical balance between the countervailing influences of SRC-3 (growth promotion) and the prohibitin family (growth suppression) which together ensures a normal proliferative response to estrogen. To advance this hypothesis, we will (1) demonstrate that phosphorylation status determines SRC-3 protein stability with consequences for steroid-dependent cell proliferation in vitro;(2) disclose the in vivo effects of perturbing SRC-3 phosphorylation status on steroid-induced epithelial proliferation;(3) define the regulatory events which control REGgamma mediated degradation of SRC-3;(4) determine the mechanism by which phosphorylation status coordinately controls the protein levels and repressive functions of REA and PHB in vitro;and (5) define the in vivo corepressor functions of REA and PHB in steroid-induced epithelial cell proliferation. Mass spectrometric analysis, transcript profiling and state-of-the-art mouse genetics will be employed to successfully execute our stated aims. Apart from addressing a new control paradigm for estrogen signaling in the epithelial cell, these studies will furnish a broader conceptual framework for understanding abnormal proliferative responses to steroid-exposure. Beyond providing important new information on coregulator control of estrogen action during breast development and cancer, we believe the results from these studies will aid in the design of novel diagnostic approaches and/or therapies for the future treatment and prevention of breast cancer, regulation of fertility and other reproductive diseases.

Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Research Project (R01)
Project #
5R01HD007857-39
Application #
7846869
Study Section
Molecular and Cellular Endocrinology Study Section (MCE)
Program Officer
Yoshinaga, Koji
Project Start
1977-05-01
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
39
Fiscal Year
2010
Total Cost
$465,223
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Zhu, Bokai; Zhang, Qiang; Pan, Yinghong et al. (2017) A Cell-Autonomous Mammalian 12 hr Clock Coordinates Metabolic and Stress Rhythms. Cell Metab 25:1305-1319.e9
Rohira, Aarti D; Yan, Fei; Wang, Lei et al. (2017) Targeting SRC Coactivators Blocks the Tumor-Initiating Capacity of Cancer Stem-like Cells. Cancer Res 77:4293-4304
Han, Sang Jun; Begum, Khurshida; Foulds, Charles E et al. (2016) The Dual Estrogen Receptor ? Inhibitory Effects of the Tissue-Selective Estrogen Complex for Endometrial and Breast Safety. Mol Pharmacol 89:14-26
Lonard, David M; Xu, Jianming; O'Malley, Bert W (2015) Bufalin is a steroid receptor coactivator inhibitor-response. Cancer Res 75:1157
Han, Sang Jun; Jung, Sung Yun; Wu, San-Pin et al. (2015) Estrogen Receptor ? Modulates Apoptosis Complexes and the Inflammasome to Drive the Pathogenesis of Endometriosis. Cell 163:960-74
Wang, Lei; Yu, Yang; Chow, Dar-Chone et al. (2015) Characterization of a Steroid Receptor Coactivator Small Molecule Stimulator that Overstimulates Cancer Cells and Leads to Cell Stress and Death. Cancer Cell 28:240-52
Yi, Ping; Wang, Zhao; Feng, Qin et al. (2015) Structure of a biologically active estrogen receptor-coactivator complex on DNA. Mol Cell 57:1047-58
Kang, Yun Kyoung; Putluri, Nagireddy; Maity, Suman et al. (2015) CAPER is vital for energy and redox homeostasis by integrating glucose-induced mitochondrial functions via ERR-?-Gabpa and stress-induced adaptive responses via NF-?B-cMYC. PLoS Genet 11:e1005116
Dasgupta, Subhamoy; Putluri, Nagireddy; Long, Weiwen et al. (2015) Coactivator SRC-2-dependent metabolic reprogramming mediates prostate cancer survival and metastasis. J Clin Invest 125:1174-88
Zhu, Bokai; Gates, Leah A; Stashi, Erin et al. (2015) Coactivator-Dependent Oscillation of Chromatin Accessibility Dictates Circadian Gene Amplitude via REV-ERB Loading. Mol Cell 60:769-783

Showing the most recent 10 out of 67 publications